Child Examinations | North Tonawanda, NY

After Hour Nurse Advice Lines
phone iconPhone: (716) 807-7337
phone iconFax: (716) 807-0848
Receive our Health e-Newsletter


News for Healthier Living

Novastra Launches First-in-Human Trial of Next-Generation Immune Reprogramming Cancer Therapy for Hard-to-Treat Patients

Novastra Therapeutics ("Novastra"), a Boston-founded, clinical-stage biotechnology company developing next-generation immune reprogramming therapies for cancer, today announced that its lead program, OAP-1 from its OmniAntigen(tm) XIRT platform, has entered a Phase 1b clinical study in patients with advanced solid tumors.

December 9, 2025


December 15 2025

December 14 2025

December 13 2025

December 12 2025

December 11 2025

December 10 2025

December 9 2025

December 8 2025

December 7 2025

December 6 2025

December 5 2025

December 4 2025

December 3 2025

December 2 2025

December 1 2025